Decline, and Regional Disparities, in Medical Cocaine Usage in the United States

Purpose Cocaine is a stimulant with a complex history that is used in otorhinolaryngological surgeries as a local anesthetic and vasodilator. There is extensive regulation in the United States for the storage and disposal of this Schedule II drug, potentially incentivizing health care professionals to avoid use. This descriptive study characterized medical cocaine use in the United States.

Methods Retail drug distribution from 2002-2017 in units of grams of weight was extracted for each state from the Drug Enforcement Administration’s Automation of Reports and Consolidated Orders System database, which reports on medical, research, and analytical-chemistry use. The percent of buyers (hospitals, pharmacies, providers) was obtained. Use per state, corrected for population, was determined. Available data on cocaine use, as reported by the Medicare and Medicaid programs for 2013 – 2017, also were examined.

Results Medical cocaine use in the US, measured on the basis of mass, decreased 62.5% from 2002 to 2017. Hospitals accounted for 84.9% and practitioners for 9.9% of cocaine distribution in 2017. The number of pharmacies nationwide carrying cocaine dropped by 69.4% to 206. The percent of all US hospitals, practitioners, and pharmacies that carried cocaine in 2017 was 38.4%, 2.3%, and 0.3%, respectively. There was a seven-fold difference in distribution per state in 2002 (South Dakota = 76.1 mg/100 persons, Delaware = 10.1 mg/100 persons). Similarly, there was a ten-fold regional disparity observed for 2017. Relative to the average state, those reporting the highest values (Montana = 20.1 and North Dakota = 24.1 mg/100 persons), were significantly elevated. Cocaine use within the Medicare and Medicaid programs was negligible.

Conclusion Medical cocaine use across the United States exhibited a pronounced decline over a fifteen-year period. If this pattern continues, licit cocaine will soon become an obscure pharmacological relic of interest only to analytical chemists and medical historians.

1. Question: How has medical use of cocaine, a local anesthetic and vasoconstrictor administered for otorhinolaryngological surgeries and some diagnostic procedures, changed in the United States?

2. Findings: Cocaine usage, as reported to the Drug Enforcement Administration has undergone a pronounced (62.5%) decline over the past fifteen-years, while some pronounced regional differences were noted.

3. Meaning: Although cocaine has played a key role in the history of anesthesia, the development of safer and non-controlled alternatives may continue to supplant this agent in contemporary use.